Cognition Pharmaceuticals LLC Patent applications |
Patent application number | Title | Published |
20140194524 | Methods for Treating Alzheimer's Disease - Cognitive impairments in humans with Alzheimer's disease are treated by administering a composition that includes an amphetamine compound. Memory, attention and executive function can be improved following administration of the amphetamine compound. | 07-10-2014 |
20130231395 | METHODS FOR TREATING ALZHEIMER'S DISEASE - Cognitive impairments in humans with Alzheimer's disease are treated by administering a composition that includes an amphetamine compound. Memory, attention and executive function can be improved following administration of the amphetamine compound. | 09-05-2013 |
20120142785 | METHODS FOR TREATING ALZHEIMER'S DISEASE - Alzheimer's disease is treated with an amphetamine compound. In one embodiment, the method includes administering an l-amphetamine compound. In another embodiment, the method includes administering an l-methamphetamine compound. | 06-07-2012 |
20100022658 | Methods for treating cognitive impairment in humans - Cognitive impairments in humans with multiple sclerosis are treated and cognition is improved with an amphetamine compound. In one embodiment, the method includes administering an l-amphetamine compound. In another embodiment, the method includes administering an l-methamphetamine compound. | 01-28-2010 |
20100010097 | Methods for treating mild cognitive impairment and alzheimer's disease - Mild cognitive impairment and Alzheimer's disease are treated with an amphetamine compound. In one embodiment, the method includes administering an l-amphetamine compound. In another embodiment, the method includes administering an l-methamphetamine compound. | 01-14-2010 |